⌘K

Login Start Free

Home/Filings/4/0001213900-18-013294

4//SEC Filing

Bell John K 4

Accession 0001213900-18-013294

CIK 0001498382other

View on SEC.gov Company Profile

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:05 PM ET

Size

4.9 KB

Accession

0001213900-18-013294

Insider Transaction Report

Form 4

Period: 2018-09-28

DelMar Pharmaceuticals, Inc.DMPI

Director

Transactions

Other
Common Stock
2018-09-28$3.20/sh+282$902→ 96,147 total(indirect: Held by Onbelay Capital Inc.)

Footnotes (1)

[F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1

filerCIK 0001569585

Filing Metadata

Form type: 4
Filed: Sep 30, 8:00 PM ET
Accepted: Oct 1, 4:05 PM ET
Size: 4.9 KB

View on SEC.gov